President Donald Trump and nine major drugmakers have agreed to cut prices on select medications, aiming to ease costs for U.S. patients and address mounting public anger over drug pricing.
President Donald Trump and AstraZeneca unveiled a new US drug pricing deal at the White House, aiming to lower prescription costs and expand patient access, sources told Reuters.